Abstract

Translationally Controlled Tumor Protein: A Key Target to Abrogate DNA Repair and Therapeutic Resistance in Cancer

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
SNP rs4971059 predisposes to breast carcinogenesis and chemoresistance via TRIM46-mediated HDAC1 degradation.
Yang Yang ... Xiaodi Wu
The EMBO journal | VOL. 40
Yang Yang, et. al.Yang Yang ... Xiaodi Wu
30 Aug 2021
New frontiers in therapeutic resistance in cancer
Thérèse Gagnon-Kugler ... Gerald Batist
Expert Review of Anticancer Therapy | VOL. 12
Thérèse Gagnon-Kugler, et. al.Thérèse Gagnon-Kugler ... Gerald Batist
01 Jul 2012
MicroRNAs Tune Oxidative Stress in Cancer Therapeutic Tolerance and Resistance
Wen Cai Zhang
International Journal of Molecular Sciences | VOL. 20
Wen Cai ZhangWen Cai Zhang
03 Dec 2019
Defining the Differentiation States of Multiple Myeloma at Single Cell Resolution Reveals Opportunities for Immunotherapy
... Praveen Anand
Blood | VOL. 134
, et. al. ... Praveen Anand
13 Nov 2019
View more papers

More From: Journal of Cancer Research and Therapeutic Oncology

Paper Title
Journal
Date
Author
Translationally Controlled Tumor Protein: A Key Target to Abrogate DNA Repair and Therapeutic Resistance in Cancer
Journal of Cancer Research and Therapeutic Oncology | VOL. 10
01 Jan 2021
-
-
Journal of Cancer Research and Therapeutic Oncology | VOL. 10
--
01 Jan 2021
Ribociclib Improves Clinical Outcomes in Breast Cancer Brain Metastases: A Case Report
Stefania Guarino
Journal of Cancer Research and Therapeutic Oncology | VOL. 10
Stefania GuarinoStefania Guarino
01 Jan 2021
Osseous Metastases of Renal Epithelioid Angiomyolipoma with Dramatic Response Through mTOR Inhibitor Therapy
SL Barton
Journal of Cancer Research and Therapeutic Oncology | VOL. 9
SL BartonSL Barton
01 Nov 2021
View more papers